Evidence map›Paper›PMID 42505648›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Evaluation of Short Versus Long Course of Tobramycin Combined with Piperacillin/Tazobactam Against Antibiotic-Resistant

Yalew M Wale, Jason A Roberts, Hayoung Won, Sheethal Reghu, Dusan Marjanovic, Getnet M Assefa, Budi Permana, Brian Ford, Fekade B Sime

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yalew M WaleFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.
Jason A RobertsFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.
Hayoung WonFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.
Sheethal ReghuFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.ORCID 0000-0001-5132-5196
Dusan MarjanovicFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.ORCID 0009-0000-5733-937X
Getnet M AssefaFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.ORCID 0000-0002-8367-5315
Budi PermanaInstitute for Molecular Bioscience, The University of Queensland, Brisbane 4029, Australia.ORCID 0000-0002-9953-113X
Brian FordFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.
Fekade B SimeFrazer Institute, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane 4029, Australia.ORCID 0000-0003-4061-2063

Funding

National Health and Medical Research Council APP2007007
6 · The paper itself

Abstract

Aminoglycosides are commonly partnered with β-lactam antibiotics for empirical treatment of severe Gram-negative bacterial infections, including those caused by

Indexed as

aminoglycoside therapyhollow fibre infection modelpiperacillin/tazobactamPseudomonas aeruginosatobramycin

Identifiers

PMID42505648
PMCPMC13405948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.